Jefferies analyst issued a revised price target for 4D Molecular Therapeutics (NASDAQ:FDMT) stock, lowering it to $40 from the previous $51, while maintaining a Buy rating. Currently trading at $5.48, ...
Treasury yields were mixed ahead of Fed Chair Jerome Powell’s congressional hearings and U.S. inflation data later this week. The 10-year yield rose, while the two-year yield fell.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback